Medicaid and Title X Funding for Planned Parenthood: Current Status and Impact

As of June 2026, Planned Parenthood clinics face significant financial and operational challenges due to a series of federal policy changes, judicial rulings, and funding restrictions. These developments, which intensified throughout 2025, have impacted the organization’s ability to provide contraceptive care, STI testing, and gynecological services to low-income and uninsured patients who rely on the safety net. According to KFF, the current landscape is defined by a complex interplay of state-level mitigation efforts and federal funding constraints that continue to evolve as of mid-2026.

How Federal Policy Shifts Impact Reproductive Health Access

The financial pressure on Planned Parenthood stems primarily from two sources: the federal Title X family planning program and Medicaid reimbursements. Title X is a federally funded program designed to provide family planning services to low-income and uninsured individuals. In early 2025, the program withheld grant payments to 144 Planned Parenthood sites across 20 states. Furthermore, the “One Big Beautiful Bill Act,” enacted on July 4, 2025, implemented a one-year prohibition on federal Medicaid reimbursements to Planned Parenthood clinics for services provided to Medicaid enrollees. While this specific ban is set to expire on July 4, 2026, the long-term status of these funding streams remains uncertain, with budget deliberations in Congress potentially influencing future allocations.

The Role of the Supreme Court in Medicaid Provider Networks

A significant legal development occurred on June 26, 2025, when the Supreme Court issued its decision in Medina v. Planned Parenthood South Atlantic. The ruling affirmed that state Medicaid programs may disqualify Planned Parenthood clinics from their networks of participating providers. This decision has direct consequences for Medicaid beneficiaries who rely on these clinics for a broad range of sexual and reproductive health services. Even in the absence of a federal funding ban, this judicial precedent allows individual states to exclude these clinics from their Medicaid networks, creating a fractured landscape of care access across the country.

State-Level Responses to Funding Losses

In response to federal restrictions, at least eleven states have utilized state-only funds to mitigate financial losses for reproductive health clinics, according to KFF. These strategies vary by state:

• California: Committed over $230 million in state funds and emergency grants to stabilize its network.
• Targeted Allocations: States including Maine, New Jersey, Oregon, Connecticut, Illinois, Massachusetts, and New Mexico have authorized allocations ranging from $2 million to $8 million.
• Statutory Mechanisms: Colorado, New York, and Washington have implemented budget proposals to guarantee state-level reimbursement for providers, aiming to preserve access to contraception, cancer screenings, and STI services.

Planned Parenthood Network Participation in Title X

The Title X network encompasses approximately 4,000 clinics nationwide. As of recent reporting, 247 Planned Parenthood clinics across 29 states participate in the Title X program, representing 50% of the organization’s clinics. This reflects a decrease from the 297 clinics that participated in 34 states and the District of Columbia just one year prior. Since January 2025, 57 Planned Parenthood clinics have either closed or consolidated, though the extent to which these closures are directly linked to funding losses remains a subject of ongoing analysis.

Who Relies on Planned Parenthood for Medicaid-Covered Care?

Data from the 2023 Transformed Medicaid Statistical Information System (T-MSIS) highlights the reliance of Medicaid beneficiaries on these services. Nationally, 10% of reproductive-age women covered by Medicaid who received family planning services utilized a Planned Parenthood clinic. The demographic breakdown of services provided is significant: KFF analysis of Medicaid claims indicates that among female beneficiaries ages 15 to 49 who visited a Planned Parenthood clinic in 2023, 80% received contraceptive services, over 50% received STI services, and more than 50% received gynecological services, such as Pap smears or pregnancy tests.

Looking Ahead: Budget Priorities and Future Access

The future of reproductive health funding remains a focal point in national health policy. While the 2026 federal budget resolutions do not extend the 2025 Medicaid funding ban, the potential for its continuation exists if Congress pursues further budget reconciliation measures. Additionally, the president’s 2027 budget proposal does not include funding for the Title X program, signaling a shift in programmatic priorities. As these policy discussions continue, the stability of the reproductive health safety net remains dependent on both federal legislative outcomes and the continued efforts of states to bridge funding gaps for low-income patients.